Pfizer Inc.on 9 April 2020, announced important advances in the battle against the global COVID-19 pandemic. Some o...
Takeda and CSL Behring, a provider of plasma-derived and recombinant therapies based in King of Prussia, PA, on 6 April ...
I-Mab Biopharma, a clinical stage biopharmaceutical company committed to the discovery, development and commercializatio...
US based CytomX Therapeutics and Japan based Astellas Pharma have entered into a strategic collaboration agreement focus...
AnHeart Therapeutics, a clinical stage oncology company focused on underserved patients in global markets, has anno...
Bayer and Curadev Pvt. Ltd., a drug discovery company based in India, on 23 March 2020 announced a research collaboratio...
Novartis Pharma has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved Zolgensma (o...
Beijing Tide Pharmaceutical Co., Ltd. (Tide), a subsidiary of Sino Biopharmaceutical Limited, and Insilico Med...
AIM ImmunoTech, an immunopharmaceutical company focused on the development of immunological, viral and multiple cancer t...
US based Atomwise, the leader in using artificial intelligence (AI) for small molecule discovery, and South Korea based ...
Japan based Takeda Pharmaceutical Company will share with members of the United States Congress that it is initiating th...
Japan based Eisai Co., Ltd. and FUJI YAKUHIN CO., LTD. have concluded a license agreement concerning dotinurad (ge...
Arctoris Ltd, an Oxford-based company that operates the world’s first fully automated drug discovery platform, has...
Codagenix, Inc., a clinical-stage biotechnology company developing prophylactic vaccines and oncolytic virus therapies h...
Borui Bio-Pharmaceutical (Suzhou) Co., Ltd. announced that it has successfully developed and synthesizes the technology ...
US based biotech company Gilead is working with health authorities in China to establish a randomized, controlled trial ...
Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, Republic of Korea has acquired ...
Astellas Pharma Inc. and FibroGen, Inc. has announced the submission of a supplemental New Drug Application (sNDA) to&nb...
